{"id":7153,"date":"2023-07-19T04:57:35","date_gmt":"2023-07-19T04:57:35","guid":{"rendered":"\/\/smallcapscn.x5view.co\/?p=7153"},"modified":"2023-08-29T17:58:40","modified_gmt":"2023-08-29T17:58:40","slug":"imugene-granted-patent-protect-cf33-family-oncolytic-virotherapies","status":"publish","type":"post","link":"https:\/\/smallcapscn.x5view.co\/?p=7153","title":{"rendered":"Imugene \u83b7\u5f97\u4e13\u5229\u4fdd\u62a4 CF33 \u7cfb\u5217\u6eb6\u7624\u75c5\u6bd2\u7597\u6cd5"},"content":{"rendered":"<p>\u5904\u4e8e\u4e34\u5e8a\u9636\u6bb5\u7684\u514d\u75ab\u80bf\u7624\u5b66\u516c\u53f8Imugene\uff08\u6fb3\u5927\u5229\u4e9a\u8bc1\u5238\u4ea4\u6613\u6240\u80a1\u7968\u4ee3\u7801\uff1aIMU\uff09\u6536\u5230\u4e86\u7f8e\u56fd\u4e13\u5229\u5546\u6807\u5c40\uff08US Patent and Trademark Office\uff09\u7684\u4e13\u5229\u8bb8\u53ef\u901a\u77e5\uff0c\u8be5\u4e13\u5229\u4fdd\u62a4\u5176\u4e3b\u8981\u7684\u6eb6\u7624\u75c5\u6bd2\u7597\u6cd5CF33\uff0c\u4ee5\u53caVaxinia\uff08CF33-hNIS\uff09\u548cCheckVacc\uff08CF33-hNIS-antiPDL1\uff09\u53d8\u4f53\u3002<\/p>\n<p>\u540d\u4e3a\u201c\u5d4c\u5408\u75d8\u75c5\u6bd2\u7ec4\u5408\u7269\u53ca\u5176\u7528\u9014\u201d\u7684\u4e13\u5229\u4fdd\u62a4\u8bb8\u53ef\u5019\u9009\u836f\u7269\u7684\u7ec4\u5408\u7269\u65b9\u6cd5\u548c\u4f7f\u7528\u65b9\u6cd5\u76f4\u81f3 2037 \u5e74\u3002<\/p>\n<p>Imugene \u9996\u5e2d\u6267\u884c\u5b98 Leslie Chong \u8868\u793a\uff0c\u8fd9\u662f\u4e00\u9879\u91cc\u7a0b\u7891\u5f0f\u7684\u6210\u5c31\u3002<\/p>\n<p>\u5979\u8bf4\uff1a\u201c\u7f8e\u56fd\u4e13\u5229\u5546\u6807\u5c40\u4e3a CF33 \u6eb6\u7624\u75c5\u6bd2\u5bb6\u65cf\u6388\u4e88\u7684\u4e13\u5229\u8bb8\u53ef\u662f\u5411\u524d\u8fc8\u51fa\u7684\u5173\u952e\u4e00\u6b65\uff0c\u4e5f\u662f\u5bf9\u6211\u4eec\u800c\u8a00\u7279\u522b\u91cd\u8981\u7684\u91cc\u7a0b\u7891\uff0c\u56e0\u4e3a\u7f8e\u56fd\u662f\u4e16\u754c\u4e0a\u6700\u5927\u7684\u533b\u7597\u4fdd\u5065\u5e02\u573a\u3002\u201d<\/p>\n<h2>\u5d4c\u5408\u75d8\u82d7\u75d8\u75c5\u6bd2<\/h2>\n<p>CF33 \u662f\u4e00\u79cd\u5d4c\u5408\u75d8\u82d7\u75d8\u75c5\u6bd2\uff0c\u6765\u81ea\u53d1\u660e\u5bb6 Yuman Fong \u6559\u6388\u7684\u5b9e\u9a8c\u5ba4\uff0cYuman Fong \u6559\u6388\u662f\u4e16\u754c\u8457\u540d\u7684\u52a0\u5229\u798f\u5c3c\u4e9a\u5dde\u5e0c\u671b\u4e4b\u57ce\u533b\u7597\u4e2d\u5fc3\u5916\u79d1\u80bf\u7624\u5b66 Sangiacomo \u5bb6\u65cf\u4e3b\u5e2d\u3002<\/p>\n<p>\u4ed6\u4e5f\u662f\u6eb6\u7624\u75c5\u6bd2\u9886\u57df\u7684\u8457\u540d\u4e13\u5bb6\u3002<\/p>\n<p>\u8be5\u5019\u9009\u836f\u7269\u62e5\u6709\u5728\u6570\u767e\u4e07\u4eba\u4e2d\u5b89\u5168\u4f7f\u7528\u7684\u8bb0\u5f55\uff0c\u56e0\u4e3a\u5b83\u662f 20 \u4e16\u7eaa 80 \u5e74\u4ee3\u6d88\u706d\u81f4\u547d\u5929\u82b1\u75c5\u6bd2\u7684\u5168\u7403\u75ab\u82d7\u7684\u6d3b\u6027\u6210\u5206\u3002<\/p>\n<p>\u6eb6\u7624\u75c5\u6bd2\u65e8\u5728\u9009\u62e9\u6027\u6740\u6b7b\u80bf\u7624\u7ec6\u80de\u5e76\u6fc0\u6d3b\u9488\u5bf9\u764c\u7ec6\u80de\u7684\u514d\u75ab\u7cfb\u7edf\uff0c\u6709\u53ef\u80fd\u6539\u5584\u4e34\u5e8a\u53cd\u5e94\u548c\u751f\u5b58\u3002<\/p>\n<h2>\u57fa\u56e0\u7ec4\u5e8f\u5217<\/h2>\n<p>\u6765\u81ea\u591a\u79cd\u75d8\u82d7\u75c5\u6bd2\u682a\u7684\u8bb8\u591a\u57fa\u56e0\u7ec4\u5e8f\u5217\u5df2\u88ab\u7ec4\u5408\u751f\u6210 CF33\uff0cImugene \u79f0\u4e4b\u4e3a\u201c\u65b0\u7684\u3001\u66f4\u5b89\u5168\u548c\u66f4\u6709\u6548\u7684\u75c5\u6bd2\u201d\u3002<\/p>\n<p>CF33 Vaxinia \u542b\u6709\u4eba\u7c7b\u7898\u5316\u94a0\u540c\u5411\u8f6c\u8fd0\u4f53 (hNIS) \u57fa\u56e0\uff0c\u8be5\u57fa\u56e0\u80fd\u591f\u901a\u8fc7\u6210\u50cf\u6280\u672f\u8ffd\u8e2a\u4f53\u5185\u75c5\u6bd2\u5e76\u4ecb\u5bfc\u9776\u5411\u653e\u5c04\u6cbb\u7597\u3002<\/p>\n<p>CF33 CheckVacc \u8fd8\u542b\u6709 hNIS\uff0c\u5e76\u201c\u6b66\u88c5\u201d\u6709\u6297 PD-L1 \u57fa\u56e0\uff0c\u53ef\u589e\u5f3a\u6297\u764c\u514d\u75ab\u6cbb\u7597\u3002<\/p>\n<h2>\u4e34\u5e8a\u524d\u8bd5\u9a8c<\/h2>\n<p>\u6240\u6709 CF33 \u53d8\u4f53\u7684\u5b89\u5168\u6027\u5df2\u5728\u8bb8\u591a\u4e34\u5e8a\u524d\u8bd5\u9a8c\u4e2d\u5f97\u5230\u8bc1\u660e\uff0c\u5e76\u4e14\u6709\u8bc1\u636e\u8868\u660e\u5177\u6709\u5c40\u90e8\u548c\u5168\u8eab\u6297\u80bf\u7624\u53cd\u5e94\u3002<\/p>\n<p>\u201c\u901a\u8fc7\u4f7f\u7528 CF33\uff0c\u6211\u4eec\u5e0c\u671b\u63d0\u9ad8\u76ee\u524d\u6cbb\u7597\u65b9\u6cd5\u96be\u4ee5\u6cbb\u7597\u7684\u764c\u75c7\u60a3\u8005\u7684\u4e34\u5e8a\u83b7\u76ca\u548c\u751f\u6d3b\u8d28\u91cf\uff0c\u201dChong \u5973\u58eb\u8bf4\u3002<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u5904\u4e8e\u4e34\u5e8a\u9636\u6bb5\u7684\u514d\u75ab\u80bf\u7624\u5b66\u516c\u53f8Imugene\uff08\u6fb3\u5927\u5229\u4e9a\u8bc1\u5238\u4ea4\u6613\u6240\u80a1\u7968\u4ee3\u7801\uff1aIMU\uff09\u6536\u5230\u4e86\u7f8e\u56fd\u4e13\u5229\u5546\u6807\u5c40\uff08US Patent and Trademark Office\uff09\u7684\u4e13\u5229\u8bb8\u53ef\u901a\u77e5\uff0c\u8be5\u4e13\u5229\u4fdd\u62a4\u5176\u4e3b\u8981\u7684\u6eb6\u7624\u75c5\u6bd2\u7597\u6cd5CF33\uff0c\u4ee5\u53caVaxinia\uff08CF33-hNIS\uff09\u548cCheckVacc\uff08CF33-hNIS-antiPDL1\uff09\u53d8\u4f53\u3002 \u540d\u4e3a\u201c\u5d4c\u5408\u75d8\u75c5\u6bd2\u7ec4\u5408\u7269\u53ca\u5176\u7528\u9014\u201d\u7684\u4e13\u5229\u4fdd\u62a4\u8bb8\u53ef\u5019\u9009\u836f\u7269\u7684\u7ec4\u5408\u7269\u65b9\u6cd5\u548c\u4f7f\u7528\u65b9\u6cd5\u76f4\u81f3 2037 \u5e74\u3002 Imugene \u9996\u5e2d\u6267\u884c\u5b98 Leslie Chong \u8868\u793a\uff0c\u8fd9\u662f\u4e00\u9879\u91cc\u7a0b\u7891\u5f0f\u7684\u6210\u5c31\u3002 \u5979\u8bf4\uff1a\u201c\u7f8e\u56fd\u4e13\u5229\u5546\u6807\u5c40\u4e3a CF33 \u6eb6\u7624\u75c5\u6bd2\u5bb6\u65cf\u6388\u4e88\u7684\u4e13\u5229\u8bb8\u53ef\u662f\u5411\u524d\u8fc8\u51fa\u7684\u5173\u952e\u4e00\u6b65\uff0c\u4e5f\u662f\u5bf9\u6211\u4eec\u800c\u8a00\u7279\u522b\u91cd\u8981\u7684\u91cc\u7a0b\u7891\uff0c\u56e0\u4e3a\u7f8e\u56fd\u662f\u4e16\u754c\u4e0a\u6700\u5927\u7684\u533b\u7597\u4fdd\u5065\u5e02\u573a\u3002\u201d \u5d4c\u5408\u75d8\u82d7\u75d8\u75c5\u6bd2 CF33 \u662f\u4e00\u79cd\u5d4c\u5408\u75d8\u82d7\u75d8\u75c5\u6bd2\uff0c\u6765\u81ea\u53d1\u660e\u5bb6 Yuman Fong \u6559\u6388\u7684\u5b9e\u9a8c\u5ba4\uff0cYuman Fong \u6559\u6388\u662f\u4e16\u754c\u8457\u540d\u7684\u52a0\u5229\u798f\u5c3c\u4e9a\u5dde\u5e0c\u671b\u4e4b\u57ce\u533b\u7597\u4e2d\u5fc3\u5916\u79d1\u80bf\u7624\u5b66 Sangiacomo \u5bb6\u65cf\u4e3b\u5e2d\u3002 \u4ed6\u4e5f\u662f\u6eb6\u7624\u75c5\u6bd2\u9886\u57df\u7684\u8457\u540d\u4e13\u5bb6\u3002 \u8be5\u5019\u9009\u836f\u7269\u62e5\u6709\u5728\u6570\u767e\u4e07\u4eba\u4e2d\u5b89\u5168\u4f7f\u7528\u7684\u8bb0\u5f55\uff0c\u56e0\u4e3a\u5b83\u662f 20 \u4e16\u7eaa 80 \u5e74\u4ee3\u6d88\u706d\u81f4\u547d\u5929\u82b1\u75c5\u6bd2\u7684\u5168\u7403\u75ab\u82d7\u7684\u6d3b\u6027\u6210\u5206\u3002 \u6eb6\u7624\u75c5\u6bd2\u65e8\u5728\u9009\u62e9\u6027\u6740\u6b7b\u80bf\u7624\u7ec6\u80de\u5e76\u6fc0\u6d3b\u9488\u5bf9\u764c\u7ec6\u80de\u7684\u514d\u75ab\u7cfb\u7edf\uff0c\u6709\u53ef\u80fd\u6539\u5584\u4e34\u5e8a\u53cd\u5e94\u548c\u751f\u5b58\u3002 \u57fa\u56e0\u7ec4\u5e8f\u5217 \u6765\u81ea\u591a\u79cd\u75d8\u82d7\u75c5\u6bd2\u682a\u7684\u8bb8\u591a\u57fa\u56e0\u7ec4\u5e8f\u5217\u5df2\u88ab\u7ec4\u5408\u751f\u6210 CF33\uff0cImugene \u79f0\u4e4b\u4e3a\u201c\u65b0\u7684\u3001\u66f4\u5b89\u5168\u548c\u66f4\u6709\u6548\u7684\u75c5\u6bd2\u201d\u3002 CF33 Vaxinia \u542b\u6709\u4eba\u7c7b\u7898\u5316\u94a0\u540c\u5411\u8f6c\u8fd0\u4f53 (hNIS) \u57fa\u56e0\uff0c\u8be5\u57fa\u56e0\u80fd\u591f\u901a\u8fc7\u6210\u50cf\u6280\u672f\u8ffd\u8e2a\u4f53\u5185\u75c5\u6bd2\u5e76\u4ecb\u5bfc\u9776\u5411\u653e\u5c04\u6cbb\u7597\u3002 CF33 CheckVacc \u8fd8\u542b\u6709 hNIS\uff0c\u5e76\u201c\u6b66\u88c5\u201d\u6709\u6297 PD-L1 \u57fa\u56e0\uff0c\u53ef\u589e\u5f3a\u6297\u764c\u514d\u75ab\u6cbb\u7597\u3002 \u4e34\u5e8a\u524d\u8bd5\u9a8c \u6240\u6709 CF33 \u53d8\u4f53\u7684\u5b89\u5168\u6027\u5df2\u5728\u8bb8\u591a\u4e34\u5e8a\u524d\u8bd5\u9a8c\u4e2d\u5f97\u5230\u8bc1\u660e\uff0c\u5e76\u4e14\u6709\u8bc1\u636e\u8868\u660e\u5177\u6709\u5c40\u90e8\u548c\u5168\u8eab\u6297\u80bf\u7624\u53cd\u5e94\u3002 \u201c\u901a\u8fc7\u4f7f\u7528 CF33\uff0c\u6211\u4eec\u5e0c\u671b\u63d0\u9ad8\u76ee\u524d\u6cbb\u7597\u65b9\u6cd5\u96be\u4ee5\u6cbb\u7597\u7684\u764c\u75c7\u60a3\u8005\u7684\u4e34\u5e8a\u83b7\u76ca\u548c\u751f\u6d3b\u8d28\u91cf\uff0c\u201dChong \u5973\u58eb\u8bf4\u3002<\/p>\n","protected":false},"author":4,"featured_media":235,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[3],"tags":[458],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v17.3 (Yoast SEO v21.0) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Imugene \u83b7\u5f97\u4e13\u5229\u4fdd\u62a4 CF33 \u7cfb\u5217\u6eb6\u7624\u75c5\u6bd2\u7597\u6cd5<\/title>\n<meta name=\"description\" content=\"\u5904\u4e8e\u4e34\u5e8a\u9636\u6bb5\u7684\u514d\u75ab\u80bf\u7624\u5b66\u516c\u53f8Imugene\uff08\u6fb3\u5927\u5229\u4e9a\u8bc1\u5238\u4ea4\u6613\u6240\u80a1\u7968\u4ee3\u7801\uff1aIMU\uff09\u6536\u5230\u4e86\u7f8e\u56fd\u4e13\u5229\u5546\u6807\u5c40\uff08US Patent and Trademark Office\uff09\u7684\u4e13\u5229\u8bb8\u53ef\u901a\u77e5\uff0c\u8be5\u4e13\u5229\u4fdd\u62a4\u5176\u4e3b\u8981\u7684\u6eb6\u7624\u75c5\u6bd2\u7597\u6cd5CF33\uff0c\u4ee5\u53caVaxinia\uff08CF33-hNIS\uff09\u548cCheckVacc\uff08CF33-hNIS-antiPDL1\uff09\u53d8\u4f53\u3002\" \/>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Imugene \u83b7\u5f97\u4e13\u5229\u4fdd\u62a4 CF33 \u7cfb\u5217\u6eb6\u7624\u75c5\u6bd2\u7597\u6cd5\" \/>\n<meta property=\"og:description\" content=\"\u5904\u4e8e\u4e34\u5e8a\u9636\u6bb5\u7684\u514d\u75ab\u80bf\u7624\u5b66\u516c\u53f8Imugene\uff08\u6fb3\u5927\u5229\u4e9a\u8bc1\u5238\u4ea4\u6613\u6240\u80a1\u7968\u4ee3\u7801\uff1aIMU\uff09\u6536\u5230\u4e86\u7f8e\u56fd\u4e13\u5229\u5546\u6807\u5c40\uff08US Patent and Trademark Office\uff09\u7684\u4e13\u5229\u8bb8\u53ef\u901a\u77e5\uff0c\u8be5\u4e13\u5229\u4fdd\u62a4\u5176\u4e3b\u8981\u7684\u6eb6\u7624\u75c5\u6bd2\u7597\u6cd5CF33\uff0c\u4ee5\u53caVaxinia\uff08CF33-hNIS\uff09\u548cCheckVacc\uff08CF33-hNIS-antiPDL1\uff09\u53d8\u4f53\u3002\" \/>\n<meta property=\"og:url\" content=\"https:\/\/smallcapscn.x5view.co\/imugene-granted-patent-protect-cf33-family-oncolytic-virotherapies\/\" \/>\n<meta property=\"og:site_name\" content=\"smallcapsCN\" \/>\n<meta property=\"article:published_time\" content=\"2023-07-19T04:57:35+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-08-29T17:58:40+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/smallcapscn.x5view.co\/wp-content\/uploads\/2023\/08\/Lithium-Australia-LieNA-patent-extraction-technology-ASX-LIT-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"640\" \/>\n\t<meta property=\"og:image:height\" content=\"400\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Imelda Cotton\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Imelda Cotton\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/imugene-granted-patent-protect-cf33-family-oncolytic-virotherapies\/\",\"url\":\"https:\/\/smallcapscn.x5view.co\/imugene-granted-patent-protect-cf33-family-oncolytic-virotherapies\/\",\"name\":\"Imugene \u83b7\u5f97\u4e13\u5229\u4fdd\u62a4 CF33 \u7cfb\u5217\u6eb6\u7624\u75c5\u6bd2\u7597\u6cd5\",\"isPartOf\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/#website\"},\"datePublished\":\"2023-07-19T04:57:35+00:00\",\"dateModified\":\"2023-08-29T17:58:40+00:00\",\"author\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/cb7c1f9e2fb318e8ea5882e380e0d90e\"},\"description\":\"\u5904\u4e8e\u4e34\u5e8a\u9636\u6bb5\u7684\u514d\u75ab\u80bf\u7624\u5b66\u516c\u53f8Imugene\uff08\u6fb3\u5927\u5229\u4e9a\u8bc1\u5238\u4ea4\u6613\u6240\u80a1\u7968\u4ee3\u7801\uff1aIMU\uff09\u6536\u5230\u4e86\u7f8e\u56fd\u4e13\u5229\u5546\u6807\u5c40\uff08US Patent and Trademark Office\uff09\u7684\u4e13\u5229\u8bb8\u53ef\u901a\u77e5\uff0c\u8be5\u4e13\u5229\u4fdd\u62a4\u5176\u4e3b\u8981\u7684\u6eb6\u7624\u75c5\u6bd2\u7597\u6cd5CF33\uff0c\u4ee5\u53caVaxinia\uff08CF33-hNIS\uff09\u548cCheckVacc\uff08CF33-hNIS-antiPDL1\uff09\u53d8\u4f53\u3002\",\"breadcrumb\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/imugene-granted-patent-protect-cf33-family-oncolytic-virotherapies\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/smallcapscn.x5view.co\/imugene-granted-patent-protect-cf33-family-oncolytic-virotherapies\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/imugene-granted-patent-protect-cf33-family-oncolytic-virotherapies\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/smallcapscn.x5view.co\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Imugene \u83b7\u5f97\u4e13\u5229\u4fdd\u62a4 CF33 \u7cfb\u5217\u6eb6\u7624\u75c5\u6bd2\u7597\u6cd5\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#website\",\"url\":\"https:\/\/smallcapscn.x5view.co\/\",\"name\":\"smallcapsCN\",\"description\":\"Just another WordPress site\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/smallcapscn.x5view.co\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/cb7c1f9e2fb318e8ea5882e380e0d90e\",\"name\":\"Imelda Cotton\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/171e68cb4a3261dde883daa03441bfa3?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/171e68cb4a3261dde883daa03441bfa3?s=96&d=mm&r=g\",\"caption\":\"Imelda Cotton\"},\"description\":\"Imelda Cotton has over 20 years experience as a journalist and communications professional. She has spent the bulk of her career in the resources sector, having also worked directly with oil and gas majors and as a journalist covering a vast array of ASX listed companies within the resources, energy, science and health sectors.\",\"url\":\"https:\/\/smallcapscn.x5view.co\/?author=4\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Imugene \u83b7\u5f97\u4e13\u5229\u4fdd\u62a4 CF33 \u7cfb\u5217\u6eb6\u7624\u75c5\u6bd2\u7597\u6cd5","description":"\u5904\u4e8e\u4e34\u5e8a\u9636\u6bb5\u7684\u514d\u75ab\u80bf\u7624\u5b66\u516c\u53f8Imugene\uff08\u6fb3\u5927\u5229\u4e9a\u8bc1\u5238\u4ea4\u6613\u6240\u80a1\u7968\u4ee3\u7801\uff1aIMU\uff09\u6536\u5230\u4e86\u7f8e\u56fd\u4e13\u5229\u5546\u6807\u5c40\uff08US Patent and Trademark Office\uff09\u7684\u4e13\u5229\u8bb8\u53ef\u901a\u77e5\uff0c\u8be5\u4e13\u5229\u4fdd\u62a4\u5176\u4e3b\u8981\u7684\u6eb6\u7624\u75c5\u6bd2\u7597\u6cd5CF33\uff0c\u4ee5\u53caVaxinia\uff08CF33-hNIS\uff09\u548cCheckVacc\uff08CF33-hNIS-antiPDL1\uff09\u53d8\u4f53\u3002","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"en_US","og_type":"article","og_title":"Imugene \u83b7\u5f97\u4e13\u5229\u4fdd\u62a4 CF33 \u7cfb\u5217\u6eb6\u7624\u75c5\u6bd2\u7597\u6cd5","og_description":"\u5904\u4e8e\u4e34\u5e8a\u9636\u6bb5\u7684\u514d\u75ab\u80bf\u7624\u5b66\u516c\u53f8Imugene\uff08\u6fb3\u5927\u5229\u4e9a\u8bc1\u5238\u4ea4\u6613\u6240\u80a1\u7968\u4ee3\u7801\uff1aIMU\uff09\u6536\u5230\u4e86\u7f8e\u56fd\u4e13\u5229\u5546\u6807\u5c40\uff08US Patent and Trademark Office\uff09\u7684\u4e13\u5229\u8bb8\u53ef\u901a\u77e5\uff0c\u8be5\u4e13\u5229\u4fdd\u62a4\u5176\u4e3b\u8981\u7684\u6eb6\u7624\u75c5\u6bd2\u7597\u6cd5CF33\uff0c\u4ee5\u53caVaxinia\uff08CF33-hNIS\uff09\u548cCheckVacc\uff08CF33-hNIS-antiPDL1\uff09\u53d8\u4f53\u3002","og_url":"https:\/\/smallcapscn.x5view.co\/imugene-granted-patent-protect-cf33-family-oncolytic-virotherapies\/","og_site_name":"smallcapsCN","article_published_time":"2023-07-19T04:57:35+00:00","article_modified_time":"2023-08-29T17:58:40+00:00","og_image":[{"width":640,"height":400,"url":"https:\/\/smallcapscn.x5view.co\/wp-content\/uploads\/2023\/08\/Lithium-Australia-LieNA-patent-extraction-technology-ASX-LIT-1.jpg","type":"image\/jpeg"}],"author":"Imelda Cotton","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Imelda Cotton"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/smallcapscn.x5view.co\/imugene-granted-patent-protect-cf33-family-oncolytic-virotherapies\/","url":"https:\/\/smallcapscn.x5view.co\/imugene-granted-patent-protect-cf33-family-oncolytic-virotherapies\/","name":"Imugene \u83b7\u5f97\u4e13\u5229\u4fdd\u62a4 CF33 \u7cfb\u5217\u6eb6\u7624\u75c5\u6bd2\u7597\u6cd5","isPartOf":{"@id":"https:\/\/smallcapscn.x5view.co\/#website"},"datePublished":"2023-07-19T04:57:35+00:00","dateModified":"2023-08-29T17:58:40+00:00","author":{"@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/cb7c1f9e2fb318e8ea5882e380e0d90e"},"description":"\u5904\u4e8e\u4e34\u5e8a\u9636\u6bb5\u7684\u514d\u75ab\u80bf\u7624\u5b66\u516c\u53f8Imugene\uff08\u6fb3\u5927\u5229\u4e9a\u8bc1\u5238\u4ea4\u6613\u6240\u80a1\u7968\u4ee3\u7801\uff1aIMU\uff09\u6536\u5230\u4e86\u7f8e\u56fd\u4e13\u5229\u5546\u6807\u5c40\uff08US Patent and Trademark Office\uff09\u7684\u4e13\u5229\u8bb8\u53ef\u901a\u77e5\uff0c\u8be5\u4e13\u5229\u4fdd\u62a4\u5176\u4e3b\u8981\u7684\u6eb6\u7624\u75c5\u6bd2\u7597\u6cd5CF33\uff0c\u4ee5\u53caVaxinia\uff08CF33-hNIS\uff09\u548cCheckVacc\uff08CF33-hNIS-antiPDL1\uff09\u53d8\u4f53\u3002","breadcrumb":{"@id":"https:\/\/smallcapscn.x5view.co\/imugene-granted-patent-protect-cf33-family-oncolytic-virotherapies\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/smallcapscn.x5view.co\/imugene-granted-patent-protect-cf33-family-oncolytic-virotherapies\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/smallcapscn.x5view.co\/imugene-granted-patent-protect-cf33-family-oncolytic-virotherapies\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/smallcapscn.x5view.co\/"},{"@type":"ListItem","position":2,"name":"Imugene \u83b7\u5f97\u4e13\u5229\u4fdd\u62a4 CF33 \u7cfb\u5217\u6eb6\u7624\u75c5\u6bd2\u7597\u6cd5"}]},{"@type":"WebSite","@id":"https:\/\/smallcapscn.x5view.co\/#website","url":"https:\/\/smallcapscn.x5view.co\/","name":"smallcapsCN","description":"Just another WordPress site","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/smallcapscn.x5view.co\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/cb7c1f9e2fb318e8ea5882e380e0d90e","name":"Imelda Cotton","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/171e68cb4a3261dde883daa03441bfa3?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/171e68cb4a3261dde883daa03441bfa3?s=96&d=mm&r=g","caption":"Imelda Cotton"},"description":"Imelda Cotton has over 20 years experience as a journalist and communications professional. She has spent the bulk of her career in the resources sector, having also worked directly with oil and gas majors and as a journalist covering a vast array of ASX listed companies within the resources, energy, science and health sectors.","url":"https:\/\/smallcapscn.x5view.co\/?author=4"}]}},"_links":{"self":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/7153"}],"collection":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=7153"}],"version-history":[{"count":1,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/7153\/revisions"}],"predecessor-version":[{"id":20951,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/7153\/revisions\/20951"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/media\/235"}],"wp:attachment":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=7153"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=7153"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=7153"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}